New drug trial offers hope for painful mouth condition
NCT ID NCT06158113
Summary
This study is testing whether the drug baricitinib can help people with moderate to severe oral lichen planus, a chronic inflammatory condition that causes painful sores in the mouth. Ten participants who haven't responded well to other treatments will take the drug daily for six months. Researchers will measure changes in mouth pain and sores, track side effects, and see if the treatment improves quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ORAL LICHEN PLANUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
UNC Dermatology and Skin Cancer Center
Chapel Hill, North Carolina, 27516, United States
Conditions
Explore the condition pages connected to this study.